Scientist and microscopeThe National Alliance of State Prostate Cancer Coalitions has joined with the United States Centers for Disease Control (CDC) and the University of Rochester to assist with the development of a dashboard intended to help men newly diagnosed with prostate cancer understand the pros and cons of different treatment options.

NASPCC’s role is to recruit newly diagnosed men to participate in one of three online studies to help evaluate the helpfulness of a decision making dashboard recently developed by the University of Rochester. Criteria for participants follows along with a link to the University of Rochester where those interested can register for the study:

We are looking for participants for three online studies:

  1. Low risk prostate cancer study - The study is open to men with newly diagnosed low risk prostate cancer. Participation in the study involves reviewing the decision tool you receive, answering a series of questions about how your treatment decision is made and how helpful you found the decision tool. You will also be asked to complete additional surveys about 3 and 9 months later that will inquire about how you are doing and how you feel about your choice of treatment. Everyone who participates will be entered into a lottery; winners will receive a $50 Amazon.com gift certificate.
  2. Intermediate risk prostate cancer study - The study is open to men with newly diagnosed intermediate risk prostate cancer. Participation in the study involves reviewing the decision tool you receive, answering a series of questions about how your treatment decision is made and how helpful you found the decision tool. You will also be asked to complete additional surveys about 3 and 9 months later that will inquire about how you are doing and how you feel about your choice of treatment. Everyone who participates will be entered into a lottery; winners will receive a $50 Amazon.com gift certificate.
  3. Prostate cancer survivor's study - We are looking for men with a history of prostate cancer willing to review the dashboard and give us feedback about what works, what doesn’t work, and how the dashboard can be improved. The study is also open to spouses, partners and other immediate family members of men with a history of prostate cancer. Participation in the study involves reviewing the decision dashboard and filling out a brief questionnaire.

Following is contact information for those interested in finding more about or joining the study: web - MCDM-MED.COM; call - (585) 275-5973; or email - This email address is being protected from spambots. You need JavaScript enabled to view it.

 

----

Photo credit: Image licensed through Creative Commons by Public Domain Pictures, Inc.